NuSkin Enterprises financials
$4.59−1.08%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $320.1M | $320.6M | $370.3M | $364.2M | $386.1M | $364.5M | $445.6M | $430.1M | $439.1M | $417.3M | $488.6M | $498.8M |
| Gross profit | $218.3M | $214.5M | $262.0M | $256.7M | $265.7M | $247.0M | $279.1M | $301.5M | $307.2M | $294.1M | $352.4M | $292.3M |
| Gross margin | 68.2% | 66.9% | 70.7% | 70.5% | 68.8% | 67.8% | 62.7% | 70.1% | 70.0% | 70.5% | 72.1% | 58.6% |
| Operating income | -$59.3M | $4.0M | $23.2M | $21.6M | $30.8M | -$9.9M | -$53.1M | $18.2M | -$125.6M | $8.8M | $16.1M | -$26.4M |
| Net income | -$249.8M | $1.8M | $14.5M | $17.1M | $21.1M | $107.5M | -$36.1M | $8.3M | -$118.3M | -$533.0K | $7.3M | -$37.0M |
| Net margin | −78.0% | 0.6% | 3.9% | 4.7% | 5.5% | 29.5% | −8.1% | 1.9% | −26.9% | −0.1% | 1.5% | −7.4% |
| Diluted EPS | $-5.14 | $0.04 | $0.28 | $0.34 | $0.43 | $2.14 | $-0.73 | $0.17 | $-2.38 | $-0.01 | $0.15 | $-0.74 |
| EBITDA | $32.2M | $18.2M | $36.2M | $33.7M | $43.8M | $29.4M | $9.2M | $35.6M | $41.4M | $34.4M | $26.1M | -$8.2M |
| Operating cash flow | $10.6M | -$3.9M | $16.6M | $27.5M | $35.8M | $389.0K | $25.8M | $31.4M | $51.2M | $3.3M | $54.2M | $51.0M |
| Free cash flow | $5.0M | -$17.6M | $5.9M | $17.6M | $35.8M | -$13.2M | $13.2M | $22.8M | $43.1M | -$9.0M | $33.8M | $39.1M |
| Diluted shares | 48.6M | 49.4M | 51.1M | 50.3M | 49.5M | 50.3M | 49.7M | 49.7M | 49.7M | 49.5M | 49.4M | 49.9M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $189.6M | $198.7M | $238.6M | $251.8M | $264.2M | $203.8M |
| Short-term investments | $1.7M | $1.8M | $1.2M | $1.2M | $1.2M | $9.8M |
| Total debt | $213.7M | $223.6M | $224.2M | $229.0M | $248.9M | $238.8M |
| Total assets | $1.12B | $1.38B | $1.41B | $1.42B | $1.44B | $1.39B |
| Total liabilities | $578.8M | $582.7M | $600.1M | $624.6M | $655.9M | $637.4M |
| Shareholders' equity | $542.7M | $794.1M | $805.2M | $799.8M | $787.8M | $754.0M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology